Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC

In a recent study posted to the medRxiv* preprint server, researchers designed a liquid biomarker panel consisting of macrophage and monocyte-related soluble factors and circulating spike proteins to understand profiles of immune dysregulation in patients with post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC).

Study: Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. Image Credit: ker_vii/Shutterstock
Study: Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. Image Credit: ker_vii/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

While the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in widespread hospitalizations and death, another cause for concern is the persistent and long-term impairment of cardiac, respiratory, and neuropsychiatric fitness in individuals infected with SARS-CoV-2. Commonly called long COVID, PASC has been reported in 12.7–87% of COVID-19 patients.

Recent research on the clinical and epidemiological characterization of PASC has indicated that reservoirs of viral ribonucleic acid (RNA) and proteins such as spike protein persisting in the body could be responsible for generating recurrent T cell immune responses that cause many of the PASC symptoms. Other studies have suggested that tissue damage due to the viral infection could be responsible for some of the organ-specific symptoms of PASC.

However, an understanding of the underlying mechanisms of PASC, such as innate and adaptive immune dysregulation, is lacking.

About the study

In the present study, the researchers designed a liquid biomarker panel to profile the plasma of 181 individuals from an earlier digital health research cohort study that included individuals with and without PASC after mild to moderate COVID-19, and a control group of uninfected individuals. The biomarkers in the panel consisted mainly of soluble monocyte and macrophage factors and circulating spike proteins from SARS-CoV-2.

The plasma levels of monocyte chemoattractant protein-1 (MCP-1/CCL2) and a range of interleukins (IL) were measured. Different types of enzyme-linked immunosorbent assays (ELISA) were used to quantify soluble macrophage activation markers such as CD206 and CD163, profile antibodies against SARS-CoV-2 spike and nucleocapsid protein, and detect circulating spike protein.

Results

The results reported strong dysregulation of macrophage- and monocyte-related soluble factors such as chemokines and pro-fibrotic and pro-inflammatory cytokines in individuals with PASC. The authors observed that, with a few exceptions, these factors display a correlation pattern independent of the ongoing symptoms of PASC.

In many individuals, especially those experiencing PASC, circulating SARS-CoV-2 spike protein were detected in the plasma. However, since the subsets of PASC cases that displayed persistent levels of viral proteins versus those with macrophage dysregulation were very small, the clinical characteristics of PASC could not be reliably correlated to these biomarkers.

The authors believe that the chemokine and cytokine data indicated the role of macrophage and monocyte factors in regulating the balance of T helper type 1 and type 2 (TH1 and TH2) cells in PASC. Interleukin 33 (IL-33) is a cytokine which is thought to play a major role in the severity of COVID-19 symptoms, along with granulocyte-macrophage colony-stimulating factor (GM-CSF). Studies suggest that IL-33 is involved in mediating the polarization of T helper type 2 cells and the development of chronic pulmonary fibrosis.

The study also identified two correlation patterns specific to PASC that involved MCP-1/CCL2, a range of interleukins, type I interferons, and soluble CD162 and CD206. These correlations suggest transitions from pro-inflammatory TH1 responses during acute COVID-19 to TH2 responses, which result in macrophage-related lung fibrosis in PASC.

The spike protein levels correlated with the antibody titers but not with any of the soluble factors. In a few cases with high circulating spike protein levels, the plasma levels of tumor necrosis factor and interleukins 1β, 6 and 8 were also high. However, the subset of participants in the cohort study exhibiting this pattern was too small to draw conclusions.

Conclusions

Overall, the results suggest that even eight months after infections, PASC patients exhibited pronounced dysregulation of macrophage- and monocyte-related soluble factors. Correlation and regression analyses found patterns involving persistently high IL-5 and IL17F levels and IL-8 and MCP-1/CCL2. The researchers could not find a correlation between the soluble macrophage or monocyte factors and the levels of circulating spike protein.

According to the authors, the study's findings indicate PASC subtypes involving immune dysregulation and viral protein reservoirs. Further studies with larger subsets are required to establish clinically defined subtypes.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:
  • Preliminary scientific report. Christoph Schultheiss, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Lidia Bosurgi, Jochen Dutzmann, Daniel Sedding, Thomas Frese, Matthias Girndt, Jessica I. Hoell, Michael Gekle, Rafael Mikolajczyk, and Mascha Binder. (2022). Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. medRxiv. doi: https://doi.org/10.1101/2022.09.18.22280022 https://www.medrxiv.org/content/10.1101/2022.09.18.22280022v1
  • Peer reviewed and published scientific report. Schultheiß, Christoph, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Lidia Bosurgi, Jochen Dutzmann, et al. 2022. “Liquid Biomarkers of Macrophage Dysregulation and Circulating Spike Protein Illustrate the Biological Heterogeneity in Patients with Post-Acute Sequelae of COVID-19.” Journal of Medical Virology 95 (1). https://doi.org/10.1002/jmv.28364. https://onlinelibrary.wiley.com/doi/10.1002/jmv.28364.

Article Revisions

  • May 15 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Chinta Sidharthan

Written by

Dr. Chinta Sidharthan

Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science writing, and herpetology. Chinta holds a Ph.D. in evolutionary biology from the Indian Institute of Science and is passionate about science education, writing, animals, wildlife, and conservation. For her doctoral research, she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the jungles of southern India. She has received the Canadian Governor General’s bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sidharthan, Chinta. (2023, May 15). Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC. News-Medical. Retrieved on June 22, 2024 from https://www.news-medical.net/news/20220922/Study-using-circulating-spike-protein-and-macrophage-dysregulation-liquid-biomarkers-reveals-heterogeneity-in-PASC.aspx.

  • MLA

    Sidharthan, Chinta. "Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC". News-Medical. 22 June 2024. <https://www.news-medical.net/news/20220922/Study-using-circulating-spike-protein-and-macrophage-dysregulation-liquid-biomarkers-reveals-heterogeneity-in-PASC.aspx>.

  • Chicago

    Sidharthan, Chinta. "Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC". News-Medical. https://www.news-medical.net/news/20220922/Study-using-circulating-spike-protein-and-macrophage-dysregulation-liquid-biomarkers-reveals-heterogeneity-in-PASC.aspx. (accessed June 22, 2024).

  • Harvard

    Sidharthan, Chinta. 2023. Study using circulating spike protein and macrophage dysregulation liquid biomarkers reveals heterogeneity in PASC. News-Medical, viewed 22 June 2024, https://www.news-medical.net/news/20220922/Study-using-circulating-spike-protein-and-macrophage-dysregulation-liquid-biomarkers-reveals-heterogeneity-in-PASC.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers engineer water-soluble histidine kinase for enhanced antibiotic drug screens